Levofloxacin is a fluoroquinolone antibiotic indicated for pneumonia, sinusitis, skin, urinary tract and prostate infections. We supply it to US manufacturers of tablets, oral solution and injection.
Data from PubChem (CID 149096) and FDA’s substance registry
CAS number
100986-85-4
Molecular formula
C18H20FN3O4
Molecular weight
361.4g/mol
FDA UNII
IUPAC name
(2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid
InChIKey
GSDSWSVVBLHKDQ-JTQLQIEISA-N
- Appearance
- Light yellowish-white to yellow-white crystals or crystalline powder.
- Solubility
- Soluble to freely soluble in water from pH 0.6 to 5.8.
Typical description, from FDA-approved labeling and pharmacopoeial monographs. The specification sent with your quote is the controlling document for any source.
Worth settling with your inquiry
Supplied as the hemihydrate. It is the S-enantiomer of ofloxacin, so check the limit for the R-enantiomer.
On the US market
- Reference product
- LevaquinNDA 020634
- Approved ANDAs
- 21 with a marketed product
- Approved forms and strengths
- Tablet 250 mg, 500 mg, 750 mg
- Injection 250 mg/50 mL, 500 mg/100 mL, 500 mg/20 mL, 750 mg/150 mL, 750 mg/30 mL
- Oral solution 250 mg/10 mL
- Ophthalmic solution 0.5%
Single-ingredient products in FDA’s Drugs@FDA database, retrieved November 2026. Strengths of salt forms are stated as the active moiety. The brand name belongs to its owner and identifies the reference product only.
Grade
USP or Ph. Eur. where a monograph exists, or your own specification.
Quantities
From development quantities for formulation work to commercial supply.
Packaging
To the manufacturer’s standard, typically fiber or HDPE drums with double polyethylene liners.
Regulatory filings
US DMF and CEP availability depends on the source. We confirm the filing status in writing with the quotation.
Documents available with a quote
- Specification and certificate of analysis
- Safety data sheet
- Method of analysis
- DMF letter of authorization, where a US DMF is filed
- GMP certificate and inspection history of the site
- Residual solvents and elemental impurities statements
- Nitrosamine risk assessment
- TSE/BSE statement
Need something else for your QA file? Email info@yogpharma.com